Inventor · disambiguated record
Mehdi Paborji
Also filed as: PABORJI MEHDI
12 granted patents·24 pending applications·164 citations·filing 1989–2020
92Inventor score
Files withPABORJI MEHDI20THERAVIDA INC12BIOTIE THERAPIES INC1BRISTOL MYERS SQUIBB CO1Biotie Therapies1
Top patents by PatentIndex Score
36 records- 0195US7678821B2Compositions for the treatment of overactive bladderTHERAVIDA INC·Filed 2006·Granted Mar 16, 2010·37 cites·22 claims
- 0294US7781472B2Therapy for the treatment of diseaseTHERAVIDA INC·Filed 2010·Granted Aug 24, 2010·27 cites·19 claims
- 0394US7666894B2Therapy for the treatment of diseaseTHERAVIDA INC·Filed 2009·Granted Feb 23, 2010·29 cites·20 claims
- 0487US8470864B2Compositions and methods for the treatment of overactive bladderPABORJI MEHDI·Filed 2010·Granted Jun 25, 2013·8 cites·11 claims
- 0583US9132124B2Combinations of solifenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Granted Sep 15, 2015·7 cites·6 claims
- 0683US8940763B2Combinations of solifenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Granted Jan 27, 2015·7 cites·11 claims
- 0782US9968556B2Pharmaceutical formulationsTHERAVIDA INC·Filed 2016·Granted May 15, 2018·4 cites·19 claims
- 0882US9744157B2Combinations of solifenacin and salivary stimulants for the treatment of overactive bladderTHERAVIDA INC·Filed 2015·Granted Aug 29, 2017·4 cites·6 claims
- 0981US10786457B2Pharmaceutical formulationsTHERAVIDA INC·Filed 2018·Granted Sep 29, 2020·1 cites·30 claims
- 1080US9415013B2Pharmaceutical formulationsPABORJI MEHDI·Filed 2011·Granted Aug 16, 2016·6 cites·19 claims
- 1168US2009275629A1Therapy for the treatment of diseaseTHERAVIDA INC·Filed 2009·Application pending·0 cites
- 1266US5216011AStable solutions of mitomycin cBRISTOL MYERS SQUIBB CO·Filed 1989·Granted Jun 1, 1993·34 cites·6 claims
- 1361US2013289087A1Compositions and methods for the treatment of overactive bladderTHERAVIDA INC·Filed 2013·Application pending·0 cites
- 1459US2014194454A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2014·Application pending·0 cites
- 1558US2013296392A1Methods for the treatment of overactive bladderTHERAVIDA INC·Filed 2013·Application pending·0 cites
- 1655US2012289531A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 1755US2012289529A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 1855US2012289530A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 1955US2012289566A1Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2055US2012289539A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2154US2017258767A1Methods for the treatment of overactive bladderTHERAVIDA INC·Filed 2016·Application pending·0 cites
- 2254US2012289564A1Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2353US10653699B2Controlled-release tozadenant formulationsBIOTIE THERAPIES INC·Filed 2016·Granted May 19, 2020·0 cites·34 claims
- 2452US2012201894A1Pharmaceutical formulations for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2551US2021093639A1Controlled-release tozadenant formulationsBiotie Therapies·Filed 2020·Application pending·0 cites
- 2646US2012289561A1Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2745US2012289567A1Combinations of darifenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2845US2012289562A1Combinations of darifenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2945US2012289560A1Combinations of tolterodine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 3045US2012289565A1Combinations of tolterodine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 3145US2012289547A1Combinations of propiverine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 3245US2012289568A1Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 3341US2005075271A1Crystalline beta2 adrenergic receptor agonistFiled 2003·Application pending·0 cites
- 3438US2012289563A1Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 3537US2014105976A1Pharmaceutical formulations of pilocarpineTHERAVIDA INC·Filed 2013·Application pending·0 cites
- 3636US2011245294A1Methods of improving quality of sleepTHERAVIDA INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mehdi Paborji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →